Revance Therapeutics shares owned by Amundi
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Amundi
from 13F filings
Historical chart of Amundi investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Amundi consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Amundi
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.9M | 3.4M | 0.85 |
| 2024-03-31 | $2.4M | 3.4M | 0.70 |
| 2023-12-31 | $2.5M | 3.4M | 0.73 |
| 2023-09-30 | $2.6M | 3.4M | 0.76 |
| 2023-06-30 | $3.6M | 3.4M | 1.05 |
| 2023-03-31 | $7.8M | 6.2M | 1.25 |
| 2022-12-31 | $6.8M | 6.2M | 1.09 |
| 2022-09-30 | $7.0M | 6.2M | 1.13 |
| 2022-06-30 | $5.1M | 6.2M | 0.83 |
| 2022-03-31 | $5.9M | 6.2M | 0.95 |
| 2021-12-31 | $5.4M | 6.2M | 0.86 |
| 2021-09-30 | $7.2M | 6.2M | 1.15 |